La cadena de opciones muestra datos clave de las opciones de acciones de Intuitive Surgical a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Intuitive Surgical..

Intuitive Surgical (NASDAQ:ISRG) Bolsa, Cadena de Opciones

Intuitive Surgical

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.

Intuitive Surgical Inc

INTUITIVE SURGICAL ORD

On CNBC's &#8220;Mad Money Lightning Round,&#8221; <a href="https://www.benzinga.com/topic/jim-cramer">Jim Cramer recommended</a> buying Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
On Oct. 17, Intuitive Surgical reported third-quarter revenue of $2.04 billion, beating the consensus estimate of $2 billion. The robotic-assisted surgery company reported third-quarter adjusted earnings of $1.84 per share, beating analyst estimates of $1.63 per share, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Kimco Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>) is a &#8220;great operator, just own it right through,&#8221; he said.
On Oct. 1, Kimco Realty announced the acquisition of Waterford Lakes Town Center, a 976,000-square-foot signature asset spanning 79 acres in Orlando, Florida, for $322 million, including the assumption of a $164 million mortgage.
&#8220;That is such a hard story to understand,&#8221; Cramer said when asked about Nutanix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTNX#NASDAQ">NTNX</a>).
On Oct. 28, Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $71 to $72.
The &#8220;Mad Money&#8221; host said CrowdStrike Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is a buy.
On Oct. 22, CrowdStrike partnered with Fortinet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) to enhance endpoint and firewall protection by integrating its AI-native security from the Falcon platform with FortiGate next-generation firewalls (NGFW).
Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) is a &#8220;high speculative&#8221; stock, he said.
On Oct. 24, Keybanc analyst Michael Leshock maintained Rocket Lab with an Overweight and raised the price target from $11 to $12.
Price Action:
<ul>
<li>Intuitive Surgical shares gained 1.1% to settle at $516.31 on Tuesday.</li>
<li>Kimco shares declined 0.9% to close at $23.67 on Tuesday.</li>
<li>Nutanix shares rose 1.3% to settle at $64.97 during the session.</li>
<li>CrowdStrike shares gained 3.2% to settle at $310.94 on Tuesday.</li>
<li>Rocket Lab gained 1.9% to settle at $11.47 on Tuesday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41599928/top-3-tech-and-telecom-stocks-which-could-rescue-your-portfolio-for-october">Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October</a></li>
</ul>
Photo: s_bukley/Shutterstock.com

Long Ideas

News

Markets

Media

Trading Ideas

CRWD

FTNT

ISRG

NTNX

RKLB

Jim Cramer Says Buy CrowdStrike Stock, Calls This Aerospace Manufacturer A 'High Speculative' Stock

AI-themed exchange-traded funds (ETFs) are witnessing a significant surge as asset managers capitalize on the growing enthusiasm surrounding <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence</a>. This year, over one-third of the two dozen AI-focused ETFs were launched, according to Morningstar.
What Happened: In the past week alone, three new ETFs have entered the AI sector, including one that was rebranded to specifically focus on artificial intelligence, Reuters reported on Monday. The total assets of AI ETFs have now reached $4.5 billion, approaching the $5.5 billion held by nuclear power-themed ETFs and surpassing the $1.37 billion in the cannabis sector.
Daniel Sotiroff, a senior analyst at Morningstar, remarked on the trend, stating, &#8220;I&#8217;m not surprised their ranks are multiplying.&#8221; 
He emphasized that the industry&#8217;s rapid pace attracts investors eager for quick returns, according to the report.
See Also: <a href="https://www.benzinga.com/markets/equities/24/10/41560703/november-interest-rate-cut-almost-a-done-deal-as-blackout-begins-10-stocks-surging-the-most-sinc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">November Interest Rate Cut Almost A Done Deal As Blackout Begins: 10 Stocks Surging The Most Since Fed&#8217;s Last Decision</a>
As per Benzinga Pro data, here are how some of the AI-based ETFs performed over the past year:
Global X Robotics and Artificial Intelligence ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>): BOTZ, currently with net assets worth $2.51 billion and NAV of $31.59, climbed 40.39%. Its top AI-related holdings include Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and biotech firm Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>).
Global X Artificial Intelligence &amp; Technology ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NASDAQ">AIQ</a>): AIQ, which has $2.27 billion in net assets and $37.36 NAV, increased by 43.64%. Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), Cisco Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), and Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) are some of its top AI-related holdings.
iShares US Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IYW#NYSE">IYW</a>): IYW gained 50.72% in the past year. The ETF has an NAV of $155.42 and $19.24 billion in net assets. It also gives exposure to tech stocks like Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Broadcom Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) which have witnessed stellar growth, thanks to AI buzz.
Fidelity MSCI Information Technology Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTEC#NYSE">FTEC</a>): The ETF witnessed a 48.55% growth while exposing to stocks like Apple, Microsoft, Nvidia, Alphabet and Broadcom. It holds $12.05 billion in net assets. 
Why It Matters: The surge in AI-themed ETFs is part of a broader trend driven by the increasing demand for artificial intelligence technologies. Recently, Nvidia briefly surpassed Apple to become the <a href="https://www.benzinga.com/markets/equities/24/10/41551461/nvidia-overtakes-apple-as-worlds-most-valuable-company-again">world&#8217;s most valuable company</a>, fueled by the demand for its AI supercomputing chips. This highlights the growing importance of AI in the tech sector.
Moreover, the <a href="https://www.benzinga.com/news/24/10/41351070/imf-warns-ai-in-stock-trading-can-boost-efficiency-but-warns-of-increased-market-volatility">International Monetary Fund</a> (IMF) has noted AI&#8217;s potential to enhance market efficiency but warns of increased volatility and cyber threats. The IMF&#8217;s Global Financial Stability Report suggests that AI-driven trading could revolutionize markets, although its adoption remains limited. The report also cautions about the potential shift of investments to less regulated nonbank financial intermediaries, complicating market oversight.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41517027/five-us-banks-face-billions-in-losses-as-silvers-price-spike-hits-short-sellers-hard-report?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Five US Banks Face Billions In Losses As Silver&#8217;s Price Spike Hits Short Sellers Hard: Report</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Unsplash

Sector ETFs

ETFs

General

AAPL

AVGO

BOTZ

CSCO

FTEC

iShares Dow Jones US Technology Sector Index Fund

MSFT

NVDA

ORCL

More Than A Third Of AI-Based ETFs Were Launched In 2024, Focusing On Nvidia, Microsoft, Apple And Meta, Among Others: Here's How Some Of Them Have Performed This Year So Far

Financial giants have made a conspicuous bearish move on Intuitive Surgical. Our analysis of options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) revealed 8 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $426,801, and 6 were calls, valued at $285,918.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $350.0 to $520.0 for Intuitive Surgical over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Intuitive Surgical options trades today is 147.75 with a total volume of 588.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuitive Surgical's big money trades within a strike price range of $350.0 to $520.0 over the last 30 days.
<h3>Intuitive Surgical 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729888259_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$465.00</td>
<td>$253.5K</td>
<td style="text-align: right;">94</td>
<td style="text-align: right;">322</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$47.1</td>
<td>$46.7</td>
<td>$46.9</td>
<td>$500.00</td>
<td>$173.2K</td>
<td style="text-align: right;">57</td>
<td style="text-align: right;">42</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$168.7</td>
<td>$167.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$67.4K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">8</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$37.3</td>
<td>$36.7</td>
<td>$37.0</td>
<td>$520.00</td>
<td>$55.5K</td>
<td style="text-align: right;">92</td>
<td style="text-align: right;">15</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$170.5</td>
<td>$168.6</td>
<td>$168.6</td>
<td>$350.00</td>
<td>$50.5K</td>
<td style="text-align: right;">348</td>
<td style="text-align: right;">3</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
<h3>Present Market Standing of Intuitive Surgical</h3>
<ul>
<li>With a volume of 979,283, the price of ISRG is down -0.07% at $511.27. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 88 days.</li>
</ul>
<h3>What The Experts Say On Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $543.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $525. 
&#x2A; An analyst from Truist Securities has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $570. 
&#x2A; Consistent in their evaluation, an analyst from Baird keeps a Outperform rating on Intuitive Surgical with a target price of $565. 
&#x2A; An analyst from Raymond James persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $540. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $518. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Market Whales and Their Recent Bets on ISRG Options

Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) has outperformed the market over the past 20 years by 20.19% on an annualized basis producing an average annual return of 28.68%. Currently, Intuitive Surgical has a market capitalization of $182.11 billion. 
Buying $100 In ISRG: If an investor had bought $100 of ISRG stock 20 years ago, it would be worth $15,521.76 today based on a price of $511.30 for ISRG at the time of writing.
<h3>Intuitive Surgical's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729778412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today

In the current market session, Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) stock price is at $515.80, after a 0.59% decrease. However, over the past month, the company's stock spiked by 6.48%, and in the past year, by 93.47%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_0.png" alt="Past Year Chart" />

<h3>Intuitive Surgical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Intuitive Surgical has a lower P/E than the aggregate P/E of 263.65 of the Health Care Equipment &amp; Supplies industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1729615537_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Price Over Earnings Overview: Intuitive Surgical

Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical.
Looking at options history for Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 28% of the investors opened trades with bullish expectations and 66% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $884,979 and 10, calls, for a total amount of $2,075,713.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $250.0 to $620.0 for Intuitive Surgical over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Intuitive Surgical's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Intuitive Surgical's whale activity within a strike price range from $250.0 to $620.0 in the last 30 days. 
<h3>Intuitive Surgical Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1729531821_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$63.9</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$1.2M</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">270</td>
</tr>
<tr>
<td>ISRG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$64.0</td>
<td>$63.2</td>
<td>$63.2</td>
<td>$470.00</td>
<td>$316.0K</td>
<td style="text-align: right;">313</td>
<td style="text-align: right;">70</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$97.1</td>
<td>$94.0</td>
<td>$97.1</td>
<td>$570.00</td>
<td>$184.4K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$101.9</td>
<td>$97.4</td>
<td>$101.9</td>
<td>$580.00</td>
<td>$142.6K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">21</td>
</tr>
<tr>
<td>ISRG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$44.4</td>
<td>$44.3</td>
<td>$44.32</td>
<td>$500.00</td>
<td>$132.9K</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">54</td>
</tr>
</tbody>
</table>

<h3>About Intuitive Surgical</h3>
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets.
After a thorough review of the options trading surrounding Intuitive Surgical, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Intuitive Surgical</h3>
<ul>
<li>With a volume of 682,367, the price of ISRG is down -0.47% at $518.69. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 92 days.</li>
</ul>
<h3>What Analysts Are Saying About Intuitive Surgical</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $540.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on Intuitive Surgical, maintaining a target price of $549. 
&#x2A; An analyst from BTIG has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $535. 
&#x2A; An analyst from Piper Sandler downgraded its action to Overweight with a price target of $538. 
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Intuitive Surgical, maintaining a target price of $555. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Intuitive Surgical, which currently sits at a price target of $525. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuitive Surgical with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Smart Money Is Betting Big In ISRG Options

This week, the Vanguard S&amp;P 500 ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NASDAQ">VOO</a>) saw a roughly 0.7% gain, reflecting a broadly positive sentiment on Wall Street driven by a combination of upbeat earnings and <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41386234/strong-september-retail-sales-put-feds-next-move-in-doubt-interest-rate-cuts-are-">macroeconomic factors</a>. 
VOO, which is designed to track the performance of the S&amp;P 500, benefits from movements in its underlying components, making it a key barometer for the overall U.S. stock market.
What&#8217;s Happening: One of the major drivers for VOO's upward movement was a strong start to earnings season that boosted investor confidence. Notably, Netflix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">after reporting an earnings beat</a>.
As Netflix is a significant part of the S&amp;P 500, its performance positively influenced VOO's price. Other companies, such as Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), which jumped over 9% on earnings, further contributed to the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406234/intuitive-surgical-posts-q3-earnings-beat-these-analysts-raise-forecasts-on-dv5-upt">bullish market sentiment</a>.
On Thursday, semiconductor stocks fueled a major push for the S&amp;P 500, as <a href="https://www.benzinga.com/news/earnings/24/10/41373163/nvidia-supplier-tsmc-reports-q3-revenue-earnings-beat-amid-rising-demand-for-ai-chips">strong earnings</a> from Taiwan Semiconductor Mfg. Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSMC#NYSE">TSMC</a>) invigorated investor confidence in the tech sector.
Read Also: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/10/41407647/spy-reaches-600-billion-in-assets-oldest-us-etf-hits-milestone-as-all-time-highs-conti">SPY Reaches $600 Billion In Assets: Oldest US ETF Hits Milestone As All-Time Highs Continue</a>
This semiconductor rally played a pivotal role in driving the S&amp;P 500 higher, and by extension, VOO, as technology remains one of the largest sectors in the index.
What Else: Gold miners saw strong momentum as gold prices reached new record highs, with the VanEck Gold Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NASDAQ">GDX</a>) climbing nearly 4% Friday.
While VOO's exposure to gold miners is limited, the broader gains in commodity-related sectors helped balance weaker performances in sectors like energy.
Macroeconomic data released on Thursday also played a role in sustaining the market's positive momentum. September retail sales exceeded expectations, signaling robust consumer spending, while jobless claims fell, underscoring labor market strength. 
Although the positive data slightly diminished hopes for Federal Reserve rate cuts in November, it reinforced the view of economic resilience, which supported investor sentiment across equity markets. VOO, as a broad-market ETF, was a key beneficiary of this optimism.
Read Also: <a href="https://www.benzinga.com/exclusives/24/10/41405659/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a>

Market Vectors ETF Trust Market Vectors Gold Miners

NFLX

TSMC

What's Going On With Vanguard S&P 500 ETF (VOO) This Week?

Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept <a href="https://www.benzinga.com/markets">investor sentiment bullish.</a>
Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) surged 10% to fresh record highs after delivering a strong earnings beat. The tech-heavy Nasdaq 100 rose 0.8%, pushing its weekly performance into positive territory for the sixth consecutive week.
The S&amp;P 500 and Dow also edged higher, both on track for the sixth straight week of gains, with the Dow flirting with all-time highs.
Gold miners led industry performance as gold prices hit new record levels above $2,700 per ounce. The VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>) soared over 4%, hitting the highest level in over four years. Friday is poised to mark the fourth straight session of gains for both gold and silver, with silver jumping over 3%, heading for its best day since late September.
West Texas Intermediate (WTI) crude prices tumbled more than 2%, slipping below the $70-per-barrel mark. WTI is down over 8% for the week, on pace for its worst weekly decline since January.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) climbed 2.8% to above $68,800.
<h3 class="wp-block-heading">Friday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % change</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,352.25</td>
<td>0.8%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,870.75</td>
<td>0.5%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>43,300.82</td>
<td>0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,279.45</td>
<td>-0.1%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:55 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.5% to $585.12.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% higher to $433.01.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rose 0.8% to $495.21.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) stalled at $226.03.</li>
<li>The Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 0.9%. The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 0.6%.</li>
</ul>
<h3 class="wp-block-heading">Friday&#8217;s Stock Movers</h3>
<ul>
<li>Stocks moving in reaction to earnings reports were Intuitive Surgical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), up over 9%, Crown Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCK#NYSE">CCK</a>), up over 4%, Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>), down 6%, American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), down 2.4%, Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) down 0.4%, Schlumberger N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) down 3.3%, Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), down 1.7%, Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), down 1% and Comerica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>), up 4%. </li>
<li>Lamb Weston Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LW#NYSE">LW</a>) soared 10% following a report indicating that activist investor&nbsp;Jana Partners&nbsp;has built a 5% stake in the company.</li>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 6% after the company replaced its CEO and cut its third-quarter outlook.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41406623/netflix-should-continue-to-outperform-6-analysts-on-streaming-stocks-q3-earnings">Netflix &#8216;Should Continue To Outperform&#8217;: 6 Analysts On Streaming Stock&#8217;s Q3 Earnings</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Equities

Broad U.S. Equity ETFs

Treasuries

Econ #s

Tech

$BTC

ALLY

SPDR Dow Jones Industrial Average ETF Trust

FITB

Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?

Evercore ISI Group analyst Vijay Kumar maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a In-Line and raises the price target from $475 to $490.

Price Target

Analyst Ratings

Evercore ISI Group Maintains In-Line on Intuitive Surgical, Raises Price Target to $490

Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) Thursday reported <a href="https://www.benzinga.com/news/24/10/41399062/why-intuitive-surgical-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">upbeat earnings for its third quarter</a>.
The company reported its results amid an <a href="https://www.benzinga.com/earnings">exciting earnings season</a>. Here are some key analyst takeaways.
<ul>
<li>RBC Capital Markets <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/606ed90d9e63ea0001ef8211/shagun-singh">analyst Shagun Singh</a> reiterated an Outperform rating, while raising the price target from $525 to $555.</li>
<li>Stifel analyst Rick Wise maintained a Buy rating, while lifting the price target from $475 to $525.</li>
<li>Goldman Sachs <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/66585980a3067c00012c48c0/david-roman">analyst David Roman</a> reaffirmed a Buy rating, while raising the price target from $583 to $604.</li>
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6010072ea6fe6f000120d9a0/anthony-elian">analyst Adam Maeder</a> maintained an Overweight rating, while lifting the price target from $495 to $538.</li>
<li>Truist Securities <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/613f4c11b4035700018daeca/brandon-king">analyst Richard Newitter</a> reiterated a Buy rating and price target of $570.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
RBC Capital Markets: Intuitive Surgical reported its third-quarter sales 2% higher than estimates. This was driven by robust procedure volume growth and gross system placements, Singh said in a note. The company also reported a 12% earnings beat on "revenue drop-through and strong margins," he added.
Management raised the low end of their guidance for procedure volumes by 50 basis points (bps) to 16%-17%, with the upper end assuming that bariatric procedures stabilize at the current quarter's rates and that headwinds in Korea and China do not worsen, the analyst stated. Management also lowered their projection for operating expense growth by 50 bps at the midpoint, he added.
Stifel: Intuitive Surgical achieved "one of the fastest installed base growth rates in years, at 15.1%," Wise said. The company is well-positioned to approach 10,000 robots installed by the end of 2024.
The midpoint of the new guidance range implies around 2.6 million procedures in 2024, the analyst stated. "Just seven months following the US da Vinci 5 (dv5) approval, Intuitive is already generating meaningful post-launch growth momentum," which suggests the potential for acceleration in 2025, he further wrote.
Goldman Sachs: Intuitive Surgical reported third-quarter revenues of $2.04 billion. That&#8217;s up 17% year-on-year and ahead of consensus of $2 billion. "Against strong YTD performance, 3Q results underscore sustained momentum in the top-line and, as importantly, the significant earnings leverage and upside in the model," Roman said
The company has "multiple layers of growth," including the continued rollout of dv5 until mid-2025, uptake of the new SP platform and continued adoption of the ION diagnostics system, the analyst stated. "Importantly, with Intuitive's consistent investment in the robotic surgery ecosystem and differentiated technology, we are increasingly confident in the company further extending its competitive advantage," he further wrote.
Piper Sandler: &#8220;We were also encouraged to see another strong placement quarter for DV5 (110 systems in Q3) and hear that ISRG is tracking towards a broad launch in mid-2025," Maeder wrote in a note. Management indicated that physician feedback of the system had been strong, he added.
Leverage was another "bright spot in the quarter," as the company reported adjusted operating margins of 37.0%, well ahead of "our 33.3% bogey," the analyst stated. Although estimates have been raised, there is "ample opportunity for upside to play out going forward," he further wrote.
Truist Securities: Intuitive Surgical delivered a massive beat on DV5, at 110 versus analyst estimate of 78, Newitter said. The upside delivered by DV5 in its soft launch is "particularly encouraging." It gives greater confidence in further estimate upside and growth acceleration into 2025, when the full launch in planned, he added.
Intuitive Surgical should be able to sustain its "already substantial lead" in a large and underpenetrated robotic opportunity.
ISRG Price Action: Shares of Intuitive Surgical had risen by 8.63% to $514.59 at the time of publication on Friday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41404035/autoliv-posts-strong-sales-joins-united-states-cellular-netflix-intuitive-surgical-and-other-big-sto">Autoliv Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday</a></li>
</ul>
Courtesy of Intuitive Surgical

Earnings Beats

Reiteration

Movers

Intuitive Surgical Posts Q3 Earnings Beat, These Analysts Raise Forecasts On DV5 Uptake

BTIG analyst Ryan Zimmerman maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $518 to $535.

BTIG Maintains Buy on Intuitive Surgical, Raises Price Target to $535

U.S. stocks were mixed , with the Nasdaq Composite gaining around 100 points on Friday.
Shares of Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41403377/autoliv-surges-despite-mixed-q3-results-chinese-market-mix-drags-performance">third-quarter sales results</a>.
The company reported third-quarter adjusted earnings per share of $1.84, missing the analyst consensus of $1.95. Quarterly revenues of $2.56 billion topped the street view of $2.53 billion.
Autoliv shares jumped 5.5% to $99.13 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) gained 19% to $18.73. Amazon Web Services recently announced plans to invest over $500 million in nuclear power.</li>
<li>NANO Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>) gained 18.7% to $22.25.</li>
<li>Telephone and Data Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) climbed 18% to $29.80.</li>
<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) gained 14% to $6.01. Peloton Interactive will release its first quarter fiscal 2025 results before the opening bell on Thursday, Oct. 31.</li>
<li>Uxin Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UXIN#NASDAQ">UXIN</a>) jumped 13.1% to $6.47. Uxin recently announced a strategic partnership with Wuhan City Economic &amp; Technological Development Zone.</li>
<li>United States Cellular Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) gained 13.1% to $66.39. after the company announced the sale of a portion of its retained spectrum licenses to Verizon for $1 billion.</li>
<li>XCHG Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCH#NASDAQ">XCH</a>) gained 12.7% to $22.08.</li>
<li>ClearPoint Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) surged 11.2% to $13.42. ClearPoint Neuro will release financial results for its 2024 third quarter on Thursday, Nov. 7, after the market close.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) gained 10.5% to $759.82 following upbeat quarterly results.</li>
<li>IonQ, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NASDAQ">IONQ</a>) surged 8.8% to $13.61. IonQ will report third quarter financial results on Nov. 6.</li>
<li>Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) gained 8.8% to $515.57 following better-than-expected third-quarter financial results.</li>
<li>Nokia Oyj (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOK#NYSE">NOK</a>) gained 6.3% to $4.6150. Nokia recently company reported worse-than-expected third-quarter EPS and sales.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

CLPT

IONQ

OKLO

PTON

UXIN

Autoliv Posts Strong Sales, Joins United States Cellular, Netflix, Intuitive Surgical And Other Big Stocks Moving Higher On Friday

Piper Sandler analyst Adam Maeder reiterates Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $495 to $538.

Piper Sandler Reiterates Overweight on Intuitive Surgical, Raises Price Target to $538

Stifel analyst Rick Wise maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Buy and raises the price target from $475 to $525.

Stifel Maintains Buy on Intuitive Surgical, Raises Price Target to $525

Wells Fargo analyst Larry Biegelsen maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Overweight and raises the price target from $466 to $549.

Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $549

RBC Capital analyst Shagun Singh maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $525 to $555.

RBC Capital Maintains Outperform on Intuitive Surgical, Raises Price Target to $555

SOBR: 272% &#x7C; <a href="https://www.benzinga.com//node/41391850">SOBR Safe shares are trading higher after the company announced it filed a form RW and will not pursue a public offering at this time.</a>
&nbsp;
DRUG: 73% &#x7C; <a href="https://www.benzinga.com//node/41400342">Bright Minds Biosciences shares are trading higher. The company announced a $35 million non-brokered private placement.</a>
&nbsp;
ISRG: 9% &#x7C; <a href="https://www.benzinga.com//node/41399053">Intuitive Surgical shares are trading higher following better-than-expected Q3 financial results.</a>
&nbsp;
&nbsp;

DRUG

SOBR

Market-Moving News for October 18th

Wall Street is priming for a positive start on Friday after the major averages ended narrowly mixed in the previous session. <a href="https://www.benzinga.com/news/earnings/24/10/41391637/netflix-q3-earnings-revenue-beats-eps-tops-q4-guidance-projects-subscriber-boost-from-squid-game-nf">Positive reaction</a> to Netflix, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) earnings could provide a lift to the tech space, given earnings news flow from the sector will likely start in earnest next week. Earnings and speeches by Federal Reserve officials could set the tempo for Friday&#8217;s session. China&#8217;s third-quarter GDP rose slightly more than estimates, allaying the fears of traders. Gold continues to make record after record, while oil continues to have a volatile ride amid geopolitical tensions.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>+0.39%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>+0.17%</td>
</tr>
<tr>
<td>Dow</td>
<td>+0.03%</td>
</tr>
<tr>
<td>R2K</td>
<td>+0.46%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Friday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.23% to $583.61 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) jumped 0.51% to $493.75, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks closed narrowly mixed as traders digested a batch of mixed economic data as well as a flurry of earnings. After opening higher, the major indices experienced some volatility in the morning, although holding mostly above the unchanged line. 
Stocks gave back most of their gains in late afternoon trading before finishing on a mixed note. 
The Dow Industrials closed at fresh intraday and closing highs, thanks to a positive reaction to Travelers Companies, Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) earnings, while the S&amp;P 500 Index hit an intraday high before squandering all the gains and closing marginally lower.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.04%</td>
<td>18,373.61</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.02%</td>
<td>5,841.47</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.37%</td>
<td>43,239.05</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.25%</td>
<td>2,280.85</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
After separate reports showed strong September retail sales growth, jobless claims, which fell after Hurricane Helene&#8217;s impact wore off, and a decline in industrial production amid the Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) strike, Comerica Chief Economist Bill Adams said, &#8220;The economy is in pretty good shape.&#8221; &#8220;Since consumer spending fuels two-thirds of U.S. demand, the economy can't be doing too bad as long as consumers still have their pocketbooks open,&#8221; he said.
The economist expects the Hurricanes that devastated swathes of the Southeast in late September and early October to be a big drag on releases for October.&nbsp;This will make it difficult to read the underlying trend accurately, he said.
Calling the headwinds temporary, Adams said, &#8220;With the Fed expected to continue lowering interest rates through the turn of the year, credit-sensitive sectors of the economy should perk up in coming quarters, sustaining the economic expansion into 2025.&#8221;
See Also:<a href="https://www.benzinga.com/money/best-strategies-for-futures-trading"> Best Futures Trading Strategies in 2024</a>
Upcoming Economic Data:
<ul>
<li>The Commerce Department will release the housing starts report for September at 8:30 a.m. EDT. Economists, on average, estimate housing starts to come in at a seasonally adjusted annual rate of 1.35 million units, slightly down from the 1.36-million-unit rate in August. Building permits, an indicator of future housing starts may have declined from 1.48 million units to 1.45 million units.</li>
<li>Among the Fed speakers scheduled for the day are:
<ul>
<li>Atlanta Fed president Raphael Bostic: 9:30 a.m. EDT</li>
<li>Minneapolis Fed President Neel Kashkari: 10 a.m. EDT</li>
<li>Fed Governor Christopher Waller is due to speak at 12:10 p.m. EDT.</li>
</ul>
</li>
<li>The Atlanta Fed&#8217;s GDPNow data for the third quarter will be released at 10:30 a.m. EDT.</li>
</ul>
Stocks In Focus:
<ul>
<li>Netflix climbed about 5.75% <a href="https://www.benzinga.com/premarket">in premarket trading</a> following the streaming giant&#8217;s quarterly results.</li>
<li>Among the other stocks moving on earnings are Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) (up nearly 7%), and Western Alliance Bancorporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) (down over 5.25%.</li>
<li>Ally Financial Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), Autoliv, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>), Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>), Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), Regions Financial Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) and Schlumberger Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) and American Express Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>) are among the noteworthy <a href="https://www.benzinga.com/calendars/earnings">companies reporting ahead of the market opening</a>.</li>
<li>CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) fell over 10% after the Wall Street Journal reported that the company is naming longtime executive David Joyner as its new chief, succeeding Karen Lynch.</li>
<li>Coherent Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) fell over 6% on a negative analyst action.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures pulled back modestly but gold futures gained ground as they scaled a fresh record. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) added over 1.50% over the past 24 hours and traded just under the $68K mark.
The 10-year U.S. Treasury note yield was little changed at 4.097%.
Asian stocks closed mostly higher, led by China and Hong Kong, which rallied on the back of the Chinese third-quarter GDP data. The Japanese market benefited from the yen&#8217;s weakness. The European Central Bank&#8217;s rate cut also buoyed sentiment.
The European markets also advanced in early trading, although the U.K. market was experiencing some weakness.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41397978/hedge-fund-billionaire-daniel-loeb-bets-on-trump-win-singles-out-this-recent-buy-as">Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having &#8216;Significant Upside Potential&#8217;</a></li>
</ul>
Image Via Shutterstock

Earnings

Futures

Previews

Economics

Federal Reserve

Pre-Market Outlook

COHR

US Stocks Set To End Week Strong As Netflix Q3 Earnings Boost Optimism, Gold Hits New Highs: What's Driving Sentiment Friday?

Baird analyst David Rescott maintains Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) with a Outperform and raises the price target from $503 to $565.

Baird Maintains Outperform on Intuitive Surgical, Raises Price Target to $565

Shares of Intuitive Surgical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) rose sharply in today's pre-market trading as the company posted better-than-expected <a href="https://www.benzinga.com/news/earnings/24/10/41391471/intuitive-surgical-stock-pops-on-q3-earnings-beat-da-vinci-procedures-climb-18-regulatory-clearance">third-quarter financial results</a>.
The company also said it obtained regulatory clearance in South Korea for the da Vinci 5 surgical system in October.
Intuitive Surgical shares jumped 6.9% to $506.38 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>SOBR Safe, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) rose 95.2% to $15.52 in pre-market trading after the company announced it filed a form RW and will not pursue a public offering at this time.</li>
<li>JIADE Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JDZG#NASDAQ">JDZG</a>) gained 62.9% to $2.77 in pre-market trading after jumping around 136% on Thursday.</li>
<li>Catheter Precision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#NASDAQ">VTAK</a>) shares surged 39.8% to $0.6160 in pre-market trading.</li>
<li>Akanda Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) gained 34% to $1.30 in pre-market trading.</li>
<li>Tenon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) rose 33.2% to $4.57 in pre-market trading. Tenon Medical(R) announced issuance of three U.S. patents.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares jumped 24.7% to $6.87 in pre-market trading after gaining around 9% on Thursday.</li>
<li>cbdMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#NASDAQ">YCBD</a>) shares rose 18.6% to $0.51 in pre-market trading.</li>
<li>Jet.AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) climbed 13.6% to $0.1101 in pre-market trading after jumping over 12% on Thursday.</li>
<li>Netflix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) gained 5.8% to $727.17 in pre-market trading after the company reported stronger-than-expected third-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Orgenesis Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares dipped 48.3% to $1.65 in pre-market trading after declining around 4% on Thursday.</li>
<li>NuZee, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUZE#NASDAQ">NUZE</a>) shares fell 38.7% to $1.41 in pre-market trading after jumping 546% on Thursday. The company announced it moved its U.S. operations from California to Florida in order to develop its global business.</li>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) fell 38.7% to $0.57 in today's pre-market trading amid volatility after the company recently announced it approved the liquidation and wind-up.</li>
<li>NKGen Biotech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) fell 36.4% to $0.4455 in pre-market trading after jumping 154% on Thursday.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) shares declined 18.8% to $10.00 in pre-market trading.</li>
<li>Staffing 360 Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) declined 18.4% to $1.89 in pre-market trading after jumping 68% on Thursday.</li>
<li>MGP Ingredients, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) shares fell 16.6% to $68.06 after the company issued soft preliminary guidance and lowered its 2024 financial outlook.</li>
<li>VS MEDIA Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSME#NASDAQ">VSME</a>) shares declined 16.4% to $1.88 in pre-market trading.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares fell 15.8% to $0.3453 in pre-market trading after declining 10% on Thursday.</li>
<li>Notable Labs, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTBL#NASDAQ">NTBL</a>) fell 14.5% to $0.3250 in pre-market trading after surging 57% on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

AKAN

CETX

JDZG

JTAI

MGPI

MTEM

NKGN

NTBL

NUZE

OLMA

ORGS

PEGY

STAF

TNON

VSME

VTAK

YCBD

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

I've been bullish on Intuitive Surgical ($ISRG) for years, recognizing its dominance in the robotic-assisted surgery market and praising its sustai...

Has Intuitive Surgical (NASDAQ:ISRG) Stock's Valuation Gotten Out of Hand?

With advanced technologies like AI and machine learning, the growing prevalence of robots, and rapid demand, the AI-driven robotics industry is flourishing. Thus, fundamentally sound AI-powered robotics stocks Intuitive Surgical (ISRG), Rockwell Automation (ROK), and iRobot (IRBT) could be suitable investments. Keep reading... The AI-powered robotics industry has proliferated and is poised for further expansion in the upcoming years, fueled by the demand surge for automation and precision. Also, the ongoing labor shortage and cost reduction strategies are leaning more and more industries toward the adoption of AI robots.
Against this backdrop, investors could consider investing in quality AI-powered robotics stocks Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>), Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>), and iRobot Corporation (<a href="https://stocknews.com/stock/IRBT/">IRBT</a>) for the next industrial revolution.
Robotics is no longer just a vision but has become a reality and is transforming the operations and lives of today's generations. The robotics market is marking strong impacts in many essential end-user industries, including the medical field and industrial machinery, and even revolutionizing the home improvement market. This growth rally is to continue in the coming period as well.
Last year, the number of operational robots across the world evidenced a rapid surge and hit a new record, reaching 3.9 million units, as per the <a href="https://ifr.org/ifr-press-releases/news/top-5-robot-trends-2024">International Federation of Robotics</a>. Compelling trends like AI and machine learning, Cobots in new applications, mobile manipulators, digital twin technology, and humanoid robots substantially contribute to the market growth.
With this, the global AI robotics market is expected to hit around $17.03 billion in 2024, where the United States will emerge as the largest market with $5.64 billion in the same year. The global market is also expected to grow at a <a href="https://www.statista.com/outlook/tmo/artificial-intelligence/ai-robotics/worldwide">CAGR of 24.8%</a>, resulting in a market volume of $64.35 billion by 2030.
The <a href="https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-robots-market-120550497.html">Artificial Intelligence robots</a> market is rapidly growing with continuous advancements in AI technologies, increasing adoption, and growing demand for automation. Also, the expanding contribution of AI robotics through increased production efficiency, precision in processes, reduced operational costs, and assistance are playing pivotal roles in the adoption.
Given the industry's bright prospects, investors could consider fundamentally strong robotics stocks such as ISRG, ROK, and IRBT.
Let's discuss the fundamentals of these stocks in detail:
Intuitive Surgical, Inc. (<a href="https://stocknews.com/stock/ISRG/">ISRG</a>)
ISRG develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care internationally. It provides the da Vinci Surgical System, allowing complex surgery using a minimally invasive approach, and the Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures.
On June 5, ISRG received FDA approval for a labeling revision for its updated da Vinci X and Xi label, confirming their use in radical prostatectomy. The approval is backed by real-world data, which shows that robotic-assisted surgeries offer long-term survival rates similar to traditional methods.
During the third quarter ended September 30, 2024, ISRG's total revenue increased 16.9% year-over-year to $2.04 billion. Its non-GAAP <a href="https://www.investopedia.com/terms/g/grossprofit.asp#:~:text=Gross%20profit%2C%20or%20gross%20income,fluctuate%20compared%20to%20production%20output.">gross profit</a> grew 17.3% from the year-ago value to $1.41 billion. The company's non-GAAP income from operations of $754.90 million indicates a 21% growth from the prior-year period.
In addition, non-GAAP net income attributable to ISRG stood at $669.10 million and $1.84 per share, up 27.7% and 26% year-over-year, respectively.
Analysts expect ISRG's revenue for the fourth quarter (ending December 2024) to increase 13.9% year-over-year to $2.20 billion, and its EPS for the same quarter is expected to grow 9.4% year-over-year to $1.75. Furthermore, the company has topped the consensus revenue and EPS estimates in each of the trailing four quarters.
Shares of ISRG have gained 39.9% over the past six months and 89.2% over the past year to close the last trading session at $521.15.
ISRG's bright prospects are reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
ISRG has an A grade for Sentiment. It is ranked #59 out of 136 stocks in the <a href="https://stocknews.com/category/medical-devices-equipment/">Medical – Devices &amp; Equipment</a> industry.
To check other POWR Ratings of ISRG for Quality, Value, Momentum, Growth, and Stability, <a href="https://stocknews.com/stock/ISRG/">click here</a>.
Rockwell Automation, Inc. (<a href="https://stocknews.com/stock/ROK/">ROK</a>)
ROK provides industrial automation and digital transformation solutions internationally. The company operates in three segments, Intelligent Devices; Software &amp; Control; and Lifecycle Services.
On September 10, ROK launched Logix SIS, a cutting-edge safety instrumented system (SIS) designed to address the evolving needs of modern industrial environments. The introduction expands the company's industry-leading safety technology portfolio.
Logix SIS offers a modern and integrated safety solution, providing both SIL 2 and SIL 3 certifications for enhanced process and hybrid safety.
On July 25, ROK and Cisco, a worldwide leader in networking and security, signed a Memorandum of Understanding (MOU) to collaborate and propel the digital transformation of the industrial market in the Asia Pacific, Japan, and Greater China region.
The combined expertise empowers manufacturers to streamline their operations, boost productivity, improve sustainability, and fortify the security of their industrial networks.
ROK posted sales of $2.05 billion for the third quarter that ended June 30, 2024, of which its Lifecycle Services sales increased 11.8% year-over-year to $581.20 million. The company's adjusted net income and adjusted EPS totaled $311.30 million and $2.71 for the quarter, respectively.
The company updated its fiscal year 2024 outlook for adjusted EPS to $9.60. Also, it continues to expect inorganic sales growth of 15% for the year.
Analysts expect ROK's revenue and EPS for the second quarter (ending March 2025) to grow 1.7% and 2.2% year-over-year to $2.16 billion and $2.56, respectively. Moreover, the company surpassed the consensus EPS and revenue estimates in three of the trailing four quarters.
Over the past month, the stock has surged 3.3% to close the last trading session at $272.82.
ROK's POWR Ratings reflect its robust outlook. ROK has a B grade for Quality. It is ranked #61 among 79 stocks within the A-rated <a href="https://stocknews.com/category/industrial-machinery/">Industrial - Machinery</a> industry.
To see the other ratings of ROK for Growth, Value, Stability, Sentiment, and Momentum, <a href="https://stocknews.com/stock/ROK/">click here</a>.
iRobot Corporation (<a href="https://stocknews.com/stock/IRBT/">IRBT</a>)
IRBT designs, builds, and sells robots and home innovation products internationally. The company provides floor care products, Roomba accessories and consumables, the Braava family of automatic floor mopping robots, and Braava accessories and consumables.
On July 23, IRBT unveiled the Roomba Combo 10 Max Robot with the AutoWash&#x2122; Dock, its most advanced vacuum and mop. The 2-in-1 device independently handles refilling, recharging, washing, and self-cleaning. Powered by iRobot OS, the innovative has Enhanced Dirt Detect&#x2122; Technology allowing identification and concentration on heavy dirt areas.
For the second quarter that ended June 29, 2024, IRBT reported revenue of $166.36 million. The company's non-GAAP gross profit came in at $27.74 million for the quarter. Furthermore, the company's cash and cash equivalents and total assets stood at $108.51 million and $585.94 million as of June 29, 2024.
Analysts expect IRBT's revenue for the third quarter (ended September 2024) to grow 17.3% year-over-year to $218.41 million. For the fiscal year 2025, the company's revenue is expected to increase 3.2% year-over-year to $818.02 million.
Over the past month, IRBT's stock has surged 7.1% and 9.7% over the past six months to close the last trading session at $7.95.
IRBT's sound fundamentals are reflected in its POWR Ratings. IRBT has a B grade for Momentum. It is ranked #52 among the 57 stocks within the B-rated <a href="https://stocknews.com/category/home-improvement-goods/">Home Improvement &amp; Goods</a> industry.
To see the other ratings of IRBT for Growth, Quality, Value, Stability, and Sentiment, <a href="https://stocknews.com/stock/IRBT/">click here</a>.
What To Do Next?
Discover 10 widely held stocks that our proprietary model shows have tremendous downside potential. Please make sure none of these "death trap" stocks are lurking in your portfolio:
<a href="https://report.stocknews.com/free-report/10-stocks-to-sell/?formplacement=artbotad_10sell">10 Stocks to SELL NOW! &gt;</a>

<hr />
ISRG shares were unchanged in after-hours trading Monday. Year-to-date, ISRG has gained 53.80%, versus a 23.95% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Rjkumari Saxena</h2> <img src='https:/wp-content/uploads/2024/04/Rajkumari-Saxena_Image-1.jpeg' style="float:left; padding:5px;width:125px;">Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.<a href="https://stocknews.com/authors/?author=rajkumari-saxena">More...</a>The post <a href=https://stocknews.com/news/isrg-rok-irbt-3-ai-powered-robotics-stocks-for-the-next-industrial-revolution/>3 AI-Powered Robotics Stocks for the Next Industrial Revolution</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 AI-Powered Robotics Stocks for the Next Industrial Revolution

Baron Fifth Avenue Growth Fund Q3 2024 Shareholder Letter

Intuitive Surgical snaps six days of losses, trades in green

Stocks with cheap implied volatility – JPM

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alphatec Holdings (ATEC – Research Report), Cigna ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Alphatec Holdings (ATEC), Cigna (CI) and Intuitive Surgical (ISRG)

Healthcare Investing Finding Growth Beyond Pharmaceuticals

ADYEY

ADYYF

AGNG

AMAT

AMZN

ARGNF

ARGX

ARKG

ASML

ASMLF

ATEC

BCAP

BMED

BROE

BSQKZ

CNCR

DAVA

DDOG

DXCM

EDOC

FANG

FHLC

FTXH

GEHC

GNOM

GOOG

GOOGL

HART

HELX

HTEC

IBBQ

IDNA

IDXX

INTC

IRBT

KLAC

LABU

LRCX

MBLY

MDEV

MELI

PARA

PCAR

PILL

PINK

POOL

PSCH

RIVN

RSPH

SBIO

SBUX

SCHW

SHOP

SNOW

TEAM

TSLA

TSMWF

UTHR

VEEV

WDNA

Press Releases

Sonder Capital Appoints Kate Garrett as Managing Partner to Lead Next Generation of Growth

Intuitive Announces First Quarter Earnings

Management

Intuitive Announces Board of Directors Elections and Retirements

Health Care

Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy

Intuitive Announces Second Quarter Earnings

Intuitive President David J. Rosa Appointed to Intuitive Board of Directors

Neptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular

Comments

Intuitive Surgical

Intuitive Surgical (ISRG) Opciones

Intuitive Surgical (NASDAQ:ISRG) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL